| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |